Department of Medical Physics and Biomedical Engineering, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Radiation Oncology Department, Cancer Institute, Imam-Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Sci Rep. 2024 Feb 24;14(1):4510. doi: 10.1038/s41598-024-55197-0.
Grid therapy recently has been picking momentum due to favorable outcomes in bulky tumors. This is being termed as Spatially Fractionated Radiation Therapy (SFRT) and lattice therapy. SFRT can be performed with specially designed blocks made with brass or cerrobend with repeated holes or using multi-leaf collimators where dosimetry is uncertain. The dosimetric challenge in grid therapy is the mystery behind the lower percentage depth dose (PDD) in grid fields. The knowledge about the beam quality, indexed by TPR (Tissue Phantom Ratio), is also necessary for absolute dosimetry of grid fields. Since the grid may change the quality of the primary photons, a new [Formula: see text] should be evaluated for absolute dosimetry of grid fields. A Monte Carlo (MC) approach is provided to resolving the dosimetric issues. Using 6 MV beam from a linear accelerator, MC simulation was performed using MCNPX code. Additionally, a commercial grid therapy device was used to simulate the grid fields. Beam parameters were validated with MC model for output factor, depth of maximum dose, PDDs, dose profiles, and TPR The electron and photon spectra were also compared between open and grid fields. The d is the same for open and grid fields. The PDD with grid is lower (~ 10%) than the open field. The difference in TPR of open and grid fields is observable (~ 5%). Accordingly, TPR is still a good index for the beam quality in grid fields and consequently choose the correct [Formula: see text] in measurements. The output factors for grid fields are 0.2 lower compared to open fields. The lower depth dose with grid therapy is due to lower depth fluence with scatter radiation but it does not impact the dosimetry as the calibration parameters are insensitive to the effective beam energies. Thus, standard dosimetry in open beam based on international protocol could be used.
网格治疗最近由于在大体积肿瘤中取得的良好效果而受到关注。这被称为空间分割放射治疗(SFRT)和格子治疗。SFRT 可以使用专门设计的带有重复孔的黄铜或 Cerrobend 制成的块或使用多叶准直器来进行,其中剂量测定不确定。网格治疗中的剂量测定挑战在于网格场中较低的百分深度剂量(PDD)背后的奥秘。关于束质指数(TPR)的知识对于网格场的绝对剂量测定也是必要的。由于网格可能会改变初级光子的质量,因此应该为网格场的绝对剂量测定评估新的[Formula: see text]。蒙特卡罗(MC)方法可用于解决剂量测定问题。使用来自线性加速器的 6 MV 束,使用 MCNPX 代码进行 MC 模拟。此外,还使用商业网格治疗设备来模拟网格场。使用 MC 模型对输出因子、最大剂量深度、PDD、剂量分布和 TPR 进行了束参数验证。还比较了开放场和网格场之间的电子和光子能谱。对于开放场和网格场,d 值相同。具有网格的 PDD 比开放场低(约 10%)。开放场和网格场之间的 TPR 差异是可观察到的(约 5%)。因此,TPR 仍然是网格场中光束质量的良好指标,因此在测量中选择正确的[Formula: see text]。与开放场相比,网格场的输出因子低 0.2。由于散射辐射导致的网格治疗深度剂量较低,但由于校准参数对有效束能不敏感,因此不会影响剂量测定。因此,可以使用基于国际协议的开放束的标准剂量测定。